Persbericht Biocartis Group NV: SeptiCyte® RAPID krijgt 510(k) clearance van de US FDA

NEXT STORY
Eurobio Scientific Launches the First Pcr Test Allowing Simultaneous Sars-Cov-2 Virus Screening and Detection of the Delta and Omicron Variants in a Single Reaction
PREV STORY
Emergence of Zoonotic Infections Boosts Precision Medicine Market Growth At A Rate Of 16% As Per The Business Research Company’s Precision Medicine Global Market Report 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pluristem Completes Enrollment of 150 Patients in Phase II Intermittent Claudication Trial

Trial expands to randomize 20 more patients to receive two injections per patientData release ...

author_avatar
NASDAQ Market News

Les résultats à long terme de Libtayo® (cemiplimab-rwlc) dans le traitement du carcinome épidermoïde cutané présentés à l’ASCO 2020 montrent des réponses durables et plus prononcées au fil du temps

author_avatar
NASDAQ Market News

Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting

author_avatar
NASDAQ Market News